This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Clinical Trial

. 1979 Dec;13(4):357-60.

doi: 10.3109/00048677909159160.

A double blind comparative trial of viloxazine and amitriptyline in patients suffering from endogenous depression

L G Kiloh, R W Bartrop, J A Franklin, M D Neilson

PMID: 395939
DOI: 10.3109/00048677909159160

Clinical Trial

A double blind comparative trial of viloxazine and amitriptyline in patients suffering from endogenous depression

L G Kiloh et al. Aust N Z J Psychiatry. 1979 Dec.

. 1979 Dec;13(4):357-60.

doi: 10.3109/00048677909159160.

Authors

L G Kiloh, R W Bartrop, J A Franklin, M D Neilson

PMID: 395939
DOI: 10.3109/00048677909159160

No abstract available

PubMed Disclaimer

Similar articles

Viloxazine and amitriptyline in depressive illness. A double blind controlled trial in general practice.
Lennox IG, Asbury JF, Couldrick WG, Beswick KB. Lennox IG, et al. Practitioner. 1978 Jan;220(1315):153-6. Practitioner. 1978. PMID: 343090 Clinical Trial. No abstract available.
A double blind comparison of viloxazine and amitryptyline in involutional and endogenous depression.
Botter PA. Botter PA. Acta Psychiatr Belg. 1979 Mar-Apr;79(2):198-209. Acta Psychiatr Belg. 1979. PMID: 532690 Clinical Trial.
Viloxazine in the treatment of endogenous depression. A standard (amitriptyline) controlled clinical study.
Petrie WM, Ban TA, Wilson WH, Jamieson RC, Guy W. Petrie WM, et al. Int Pharmacopsychiatry. 1982;17(4):280-6. doi: 10.1159/000468584. Int Pharmacopsychiatry. 1982. PMID: 7185772
Viloxazine: a review of its pharmacological properties and therapeutic efficacy in depressive illness.
Pinder RM, Brogden RN, Speight TM, Avery GS. Pinder RM, et al. Drugs. 1977 Jun;13(6):401-21. doi: 10.2165/00003495-197713060-00001. Drugs. 1977. PMID: 324751 Review. No abstract available.
Amoxapine and viloxazine: review of the literature with special reference to clinical studies.
Ban TA. Ban TA. Psychopharmacol Bull. 1979 Jul;15(3):22-5. Psychopharmacol Bull. 1979. PMID: 386404 Review. No abstract available.

See all similar articles

Cited by

Unwanted symptoms in depressed patients treated with viloxazine: an algorithm for identification of illness-related symptoms.
Maistrello I, Grassi G, Bertolino A, Valerio P, Pistollato G, Soverini S. Maistrello I, et al. Eur J Clin Pharmacol. 1983;24(2):277-81. doi: 10.1007/BF00613832. Eur J Clin Pharmacol. 1983. PMID: 6840180
Age-related differences in kinetics and side-effects of viloxazine in man and their clinical implications.
Altamura AC, Melorio T, Invernizzi G, Colacurcio F, Gomeni R. Altamura AC, et al. Psychopharmacology (Berl). 1983;81(4):281-5. doi: 10.1007/BF00427563. Psychopharmacology (Berl). 1983. PMID: 6419255
Amitriptyline for depression.
Guaiana G, Barbui C, Hotopf M. Guaiana G, et al. Cochrane Database Syst Rev. 2007 Jul 18;2007(3):CD004186. doi: 10.1002/14651858.CD004186.pub2. Cochrane Database Syst Rev. 2007. PMID: 17636748 Free PMC article.

Publication types

Actions
Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Atypon
- Ovid Technologies, Inc.
Other Literature Sources
- The Lens - Patent Citations Database